ProPhase Labs, Inc. (PRPH) Total liabilities 2016–2025
ProPhase Labs, Inc. (PRPH) total liabilities at each fiscal year-end, per SEC filings.
$56.4MFY2025 · since FY2016: $6.8M → $56.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $56.4M | +0.9% |
| FY2024 | $55.8M | +31.3% |
| FY2023 | $42.5M | +77.1% |
| FY2022 | $24.0M | -21.7% |
| FY2021 | $30.7M | +47.1% |
| FY2020 | $20.8M | +1898.9% |
| FY2019 | $1.0M | -75.4% |
| FY2018 | $4.2M | +133.6% |
| FY2017 | $1.8M | -73.5% |
| FY2016 | $6.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice